DrugPatentWatch Database Preview
Collegium Pharm Inc Company Profile
» See Plans and Pricing
What is the competitive landscape for COLLEGIUM PHARM INC, and what generic alternatives to COLLEGIUM PHARM INC drugs are available?
COLLEGIUM PHARM INC has four approved drugs.
There are twenty-six US patents protecting COLLEGIUM PHARM INC drugs.
There are two hundred and forty-eight patent family members on COLLEGIUM PHARM INC drugs in thirty-seven countries and twelve supplementary protection certificates in nine countries.
Summary for Collegium Pharm Inc
| International Patents: | 248 |
| US Patents: | 26 |
| Tradenames: | 3 |
| Ingredients: | 2 |
| NDAs: | 4 |
Drugs and US Patents for Collegium Pharm Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Collegium Pharm Inc | NUCYNTA | tapentadol hydrochloride | TABLET;ORAL | 022304-002 | Nov 20, 2008 | RX | Yes | No | 7,994,364 | Start Trial | Y | Y | Start Trial | ||
| Collegium Pharm Inc | XTAMPZA ER | oxycodone | CAPSULE, EXTENDED RELEASE;ORAL | 208090-004 | Apr 26, 2016 | RX | Yes | No | 10,188,644 | Start Trial | Y | Start Trial | |||
| Collegium Pharm Inc | XTAMPZA ER | oxycodone | CAPSULE, EXTENDED RELEASE;ORAL | 208090-004 | Apr 26, 2016 | RX | Yes | No | 10,004,729 | Start Trial | Y | Start Trial | |||
| Collegium Pharm Inc | NUCYNTA ER | tapentadol hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 200533-003 | Aug 25, 2011 | RX | Yes | No | 8,075,872 | Start Trial | Y | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Collegium Pharm Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Collegium Pharm Inc | NUCYNTA | tapentadol hydrochloride | TABLET;ORAL | 022304-002 | Nov 20, 2008 | 6,071,970 | Start Trial |
| Collegium Pharm Inc | NUCYNTA ER | tapentadol hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 200533-001 | Aug 25, 2011 | 6,071,970 | Start Trial |
| Collegium Pharm Inc | NUCYNTA | tapentadol hydrochloride | TABLET;ORAL | 022304-003 | Nov 20, 2008 | 6,071,970 | Start Trial |
| Collegium Pharm Inc | NUCYNTA | tapentadol hydrochloride | SOLUTION;ORAL | 203794-001 | Oct 15, 2012 | 6,071,970 | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for COLLEGIUM PHARM INC drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Oral Solution | 20 mg/mL | ➤ Subscribe | 2013-12-30 |
| ➤ Subscribe | Extended-release Tablets | 50 mg, 100 mg, 150 mg, 200 mg, and 250 mg | ➤ Subscribe | 2012-11-20 |
| ➤ Subscribe | Tablets | x50 mg, 75 mg, and 100 mg | ➤ Subscribe | 2012-11-20 |
| ➤ Subscribe | Oral Solution | 20 mg/mL | ➤ Subscribe | 2013-12-20 |
International Patents for Collegium Pharm Inc Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| China | 1863513 | Start Trial |
| China | 1125221 | Start Trial |
| South Korea | 20120104199 | Start Trial |
| Australia | 685644 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Collegium Pharm Inc Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0693475 | CA 2010 00036 | Denmark | Start Trial | |
| 0693475 | 1190004-0.L | Sweden | Start Trial | PRODUCT NAME: TAPENTADOL; NAT. REG. NO/DATE: 42622-42628 20100910; FIRST REG.: DE 7543-7548,7661-76270" EESGODKLANDKOD="DE" EESGODKDATUM="2010-08-19" SEGODKNR="42622-42628 20100819 |
| 0693475 | SPC/GB11/031 | United Kingdom | Start Trial | PRODUCT NAME: TAPENTADOL IN THE FORM OF ITS BASE OR A SALT OF A PHYSIOLOGICALLY COMPATIBLE ACID, ESPECIALLY THE HYDROCHLORIDE SALT.; REGISTERED: DE 75043 20100819; UK PL 21727/0032 - 0050 20110204 |
| 0693475 | PA2011007 | Lithuania | Start Trial | PRODUCT NAME: TAPENTADOLUM; NAT. REGISTRATION NO/DATE: LT/1/10/2341/001 - LT/1/10/2341/66, 2011 02 19; LT/1/10/2342/001 - LT/1/10/2342/110 20110219; FIRST REGISTRATION: 75043.00.00 - 75048.00.00, 2010 08 19; 76261.00.00 - 76270.00.00 20100819 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
